Webcast Scheduled for Tomorrow, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET) Revenues of $62.5 million increased 11% sequentially compared to third quarter this year and decreased 12% compared to fourth quarter last year Management provides fiscal 23 revenue guidance of $255 million to $265 million, representing 8% to 12% growth compared to … [Read more…]
Funds Raised Will Support Mental Health Services for Pittsburgh’s LGBTQ+ Community PITTSBURGH–(BUSINESS WIRE)–Persad Center is hosting “2022 Art for Change Event” on Friday, September 9 at Stage AE on the North Shore. The event, Persad’s 35th Annual, is one of the region’s most significant art auctions. Proceeds support Persad Center’s mission of providing mental health … [Read more…]
Dr. Todd Lencz, and others in the Ethics Committee of the International Society of Psychiatric Genetics, publish concerns about polygenic embryo screening in The Lancet Psychiatry MANHASSET, N.Y.–(BUSINESS WIRE)–Genetic testing has been part of the in vitro fertilization (IVF) process for three decades and allows parents to screen embryos for illnesses. Yet, a new technique … [Read more…]
AHF thanks the Los Angeles County Board of Supervisors for proclaiming a state of emergency on monkeypox today; urges the Supervisors to immediately allocate $10M for monkeypox and STDs, and presses County health officials to develop and share their plan of action to handle the outbreak LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today thanked the … [Read more…]
BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today that it will be added to the Russell US Index Series in conjunction with the September 2022 quarterly review, effective after the US market open on Monday, September 19, 2022. Russell indexes are widely … [Read more…]
TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2022 (“Q2 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated. SECOND QUARTER 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Revenue for Q2 2022 increased by 4% to a record … [Read more…]
MedX Announces Tarek El Hoss as Sr. Vice President, Market Development and Sales MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Tarek El Hoss has been appointed as the Company’s Vice President, Market Development and Sales. Mr. El Hoss will oversee … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time). This conference call will … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that it has commenced a proposed underwritten public offering of 1,750,000 shares of its common stock. Axonics expects to grant the underwriter a 30-day option to … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it filed a lawsuit against Foresight Diagnostics Inc. for infringement of Personalis’ U.S. Patent Nos. 10,450,611, 11,299,783, and 11,384,394. These patents are part of Personalis’ intellectual property portfolio in the field of whole genome-enabled, tumor-informed molecular residual disease … [Read more…]
